Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Survival Analysis
Zeng, Donglin, Ming-Hui Chen, Joseph G. Ibrahim, Rachel Wei, Beiying Ding, Chunlei Ke, and Qi Jiang. "A counterfactual p-value approach for benefit-risk assessment in clinical trials." J Biopharm Stat 25, no. 3 (2015): 508-24.
Ni, Ai, and Jianwen Cai. "A regularized variable selection procedure in additive hazards model with stratified case-cohort design." Lifetime Data Anal 24, no. 3 (2018): 443-463.
A Gould, Lawrence, Mark Ernest Boye, Michael J. Crowther, Joseph G. Ibrahim, George Quartey, Sandrine Micallef, and Frederic Y. Bois. "Responses to discussants of 'Joint modeling of survival and longitudinal non-survival data: current methods and issues. report of the DIA Bayesian joint modeling working group'." Stat Med 34, no. 14 (2015): 2202-3.
Li, Zhiguo, Xiaofei Wang, Yuan Wu, and Kouros Owzar. "Sample size calculation for studies with grouped survival data." Stat Med 37, no. 27 (2018): 3904-3917.
Chen, Li, D Y. Lin, and Donglin Zeng. "Checking semiparametric transformation models with censored data." Biostatistics 13, no. 1 (2012): 18-31.
Joeng, Hee-Koung, Ming-Hui Chen, and Sangwook Kang. "Proportional exponentiated link transformed hazards (ELTH) models for discrete time survival data with application." Lifetime Data Anal 22, no. 1 (2016): 38-62.
Survival Rate
Diéras, Véronique, David Miles, Sunil Verma, Mark Pegram, Manfred Welslau, José Baselga, Ian E. Krop, Kim Blackwell, Silke Hoersch, Jin Xu et al. "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial." Lancet Oncol 18, no. 6 (2017): 732-742.
Kwak, Minjung, and Sin-Ho Jung. "Optimal two-stage log-rank test for randomized phase II clinical trials." J Biopharm Stat 27, no. 4 (2017): 639-658.
Owzar, Kouros, Zhiguo Li, Nancy Cox, and Sin-Ho Jung. "Power and sample size calculations for SNP association studies with censored time-to-event outcomes." Genet Epidemiol 36, no. 6 (2012): 538-48.
Ganti, Apar Kishor, Xiaofei Wang, Thomas E. Stinchcombe, Yinpeng Wang, Jeffrey Bradley, Harvey J. Cohen, Karen Kelly, Rebecca Paulus, Suresh S. Ramalingam, Everett E. Vokes et al. "Clinical prognostic model for older patients with advanced non-small cell lung cancer." J Geriatr Oncol 10, no. 4 (2019): 555-559.
Vock, David M., Michael T. Durheim, Wayne M. Tsuang, Ashley Finlen C Copeland, Anastasios A. Tsiatis, Marie Davidian, Megan L. Neely, David J. Lederer, and Scott M. Palmer. "Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation." Ann Am Thorac Soc 14, no. 2 (2017): 172-181.
Rashid, Naim U., Xianlu L. Peng, Chong Jin, Richard A. Moffitt, Keith E. Volmar, Brian A. Belt, Roheena Z. Panni, Timothy M. Nywening, Silvia G. Herrera, Kristin J. Moore et al. "Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer." Clin Cancer Res 26, no. 1 (2020): 82-92.
Wong, Kin Yau, Cheng Fan, Maki Tanioka, Joel S. Parker, Andrew B. Nobel, Donglin Zeng, Dan-Yu Lin, and Charles M. Perou. "I-Boost: an integrative boosting approach for predicting survival time with multiple genomics platforms." Genome Biol 20, no. 1 (2019): 52.
Mentz, Robert J., Phillip J. Schulte, Jerome L. Fleg, Mona Fiuzat, William E. Kraus, Ileana L. Piña, Steven J. Keteyian, Dalane W. Kitzman, David J. Whellan, Stephen J. Ellis et al. "Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)." Am Heart J 165, no. 2 (2013): 193-9.
Samsky, Marc D., Chetan B. Patel, Ashleigh Owen, Phillip J. Schulte, Jacob Jentzer, Paul B. Rosenberg, Michael G Felker, Carmelo A. Milano, Adrian F. Hernandez, and Joseph G. Rogers. "Ten-year experience with extended criteria cardiac transplantation." Circ Heart Fail 6, no. 6 (2013): 1230-8.
Jung, Sin-Ho, and Shein-Chung Chow. "On sample size calculation for comparing survival curves under general hypothesis testing." J Biopharm Stat 22, no. 3 (2012): 485-95.
Geng, Yuan, Hao Helen Zhang, and Wenbin Lu. "On optimal treatment regimes selection for mean survival time." Stat Med 34, no. 7 (2015): 1169-84.
Secord, Angeles Alvarez, Kirsten Bell Burdett, Kouros Owzar, David Tritchler, Alexander B. Sibley, Yingmiao Liu, Mark D. Starr, Chris J Brady, Heather A. Lankes, Herbert I. Hurwitz et al. "Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218." Clin Cancer Res 26, no. 6 (2020): 1288-1296.
Vock, David M., Anastasios A. Tsiatis, Marie Davidian, Eric B. Laber, Wayne M. Tsuang, Ashley Finlen C Copeland, and Scott M. Palmer. "Assessing the causal effect of organ transplantation on the distribution of residual lifetime." Biometrics 69, no. 4 (2013): 820-9.
Symposium I
Hung, H M. James. Utilities and challenges of adaptive designs in drug development., 2011.
Fine, Jason P.. An overview of competing risks data, with applications in clinical trials., 2011.
Zhao, Yingqi. Estimating Individualized Treatment Rules Using Outcome Weighted Learning., 2011.
Tzeng, Jung-Ying. A gene-trait similarity regression method for gene-level pharmacogenetics analysis., 2011.
Madigan, D. Drug safety in spontaneous reports, observational databases, and clinical trials: Can we do better?., 2011.
Chen, Liddy M.. Design consideration for complex survival models., 2011.
Wang, Xiaofei. Biased sampling and its applications in biomarker validation., 2011.
Levenson, M. Safety decision-making with multiple sources and different types of studies—recent examples from FDA Advisory Committees., 2011.
Zeng, Donglin. Estimating treatment effects with treatment switching via semi-competing risks models: An application to a colorectal cancer study., 2011.
Davidian, Marie. A robust method for estimating optimal treatment regimes., 2011.
Korn, E. Biomarker-adaptive clinical trial designs., 2011.
Parmigiani, G. Adaptive randomized trial design for patients with recurrent glioblastom., 2011.
Li, Zhiguo. Fitting Cox models with doubly censored data using spline-based marginal likelihood., 2011.
Laber, Eric B.. Adaptive inference after model selection., 2011.
Auman, Todd. Pharmacogenomic interrogation of colorectal cancer using next-generation whole exome sequencing., 2011.
Symposium II
Carpenter, William R.. Data needs for cancer comparative effectiveness research, and the Integrated Cancer Information and Surveillance System., 2012.
Simon, R. Development of Predictive Biomarkers for Molecular Targeted Therapy., 2012.
Linn, Kristin A.. IQ-Learning., 2012.
Gatsonis, C. Clinical Evaluation of Diagnostic Tests and Biomarkers in CER., 2012.
Owzar, Kouros. Challenges in genome-wide association analysis of drug-induced toxicity data from clinical trials., 2012.
Almirall, D, and Susan A. Murphy. Getting SMART about developing individualized sequences of health interventions., 2012.
Ivanova, Anastasia. Oncology Phase II trials with ordinal outcome., 2012.
Song, Rui. Penalized Q-Learning for Dynamic Treatment Regimes., 2012.
Sargent, Daniel J.. Biomarker-based clinical trials., 2012.
Bobashev, G. Prediction of the Best Treatment Assignment Using Random Forest with Regression in the Nodes., 2012.
Chow, Shein-Chung. Benefits, Challenges and Obstacles of Adaptive Clinical Trial Designs., 2012.
Symposium III
Almirall, D. Tutorial: Getting SMART about Dynamic Treatment Regimes: A Conceptual Introduction., 2014.
Rom, D. The Closure Principle Revisited., 2014.
Kidwell, KM. Addressing the Challenges and Reaping the Benefits of SMARTs., 2014.
Madar, V. Faster algorithm to control the Benjamini-Hochberg false discovery rate and its application for analysis of huge genomic data.., 2014.
Gou, J, and AC Tamhane. Hochberg Multiple Test Procedure Under Negative Dependence., 2014.
Benjamini, Y. In Hochberg’s tradition: Selective Inference for Clinical Trials., 2014.
Murphy, Susan A.. Micro-Randomized Trials & mHealth., 2014.
Rosenblum, M. Optimal, Two Stage, Adaptive Enrichment Designs for Randomized Trials, using Sparse Linear Programming., 2014.
Wang, L. Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer., 2014.
Sarkar, S. Improving Holm's procedure using pairwise dependencies., 2014.
Thall, PF. SMART Design, Conduct, and Analysis in Oncology., 2014.
Zhang, Yichi. Interpretable treatment regimes., 2014.
Wahed, AS. Baseline Covariate Adjustment in SMART Studies via Artificial Randomization., 2014.
Heyse, Joseph F.. An Overview of Multiple Testing Procedures for Categorical Data., 2014.
Laber, Eric B.. Sizing a trial for estimation of an optimal treatment regime., 2014.
Bretz, F. Tutorial: Introduction to Multiplicity in Clinical Trials., 2014.
Zhao, Yingqi. Estimation of Optimal Dynamic Treatment Regimes., 2014.
Symposium IV
Wang, Ting. Biomarker Stratified Design Enriched by Auxiliary Biomarker., 2016.
Nair, Smita. Immune-based therapies., 2016.
Zhao, Luping. Measures of Clinical Benefit in Immuno-Oncology Studies., 2016.
Wong, Kin Yau. Integration of Multiple High-dimensional Genomic Data Types for Survival Prediction., 2016.
Murphy, Susan A.. Assessing Time-Varying Causal Interactions and Treatment Effects with Applications to Mobile Health., 2016.
Chi, Eric. Getting High-throughput Arrays in Order with Convex Biclustering., 2016.
Ibrahim, Joseph G.. Network Meta-analysis for Ordinal Outcomes: Applications in Comparing Crohn's Disease Treatments., 2016.
Xie, Jichun. Multiple Testing of General Dependence by Quantile-Based Contingency Tables with an Application in Identifying Gene Co-expression Network Change Associated with Cancer Survival., 2016.
Boland, Mary Regina. Electronic Health Records and Precision Medicine: Enabling Large-Scale Discoveries Using Phenome-Wide Approaches., 2016.
Kang, Suhyun. Subgroup Detection and Sample Size Calculation with Proportional Hazards Regression for Survival Data., 2016.
Shortreed, Susan M.. Leveraging Electronic Medical Records to Better Target Suicide Prevention., 2016.
Synovitis
Li, Jialiang, Binyan Jiang, and Jason P. Fine. "Multicategory reclassification statistics for assessing improvements in diagnostic accuracy." Biostatistics 14, no. 2 (2013): 382-94.
Taxoids
Diéras, Véronique, David Miles, Sunil Verma, Mark Pegram, Manfred Welslau, José Baselga, Ian E. Krop, Kim Blackwell, Silke Hoersch, Jin Xu et al. "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial." Lancet Oncol 18, no. 6 (2017): 732-742.
Krens, Stefanie D., Howard L. McLeod, and Daniel L. Hertz. "Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy." Pharmacogenomics 14, no. 5 (2013): 555-74.
Temporomandibular Joint Disorders
Helgeson, Erika S., Qian Liu, Guanhua Chen, Michael R. Kosorok, and Eric Bair. "Biclustering via sparse clustering." Biometrics 76, no. 1 (2020): 348-358.
Brownstein, Naomi C., Jianwen Cai, Gary D. Slade, and Eric Bair. "Parameter estimation in Cox models with missing failure indicators and the OPPERA study." Stat Med 34, no. 30 (2015): 3984-96.
Testosterone
Zou, Baiming, Bo Jin, Gary G. Koch, Haibo Zhou, Stephen E. Borst, Sandeep Menon, and Jonathan J. Shuster. "On model selections for repeated measurement data in clinical studies." Stat Med 34, no. 10 (2015): 1621-33.
Tetrahydrofolates
Tamura, Roy N., Xiaohong Huang, and Dennis D. Boos. "Estimation of treatment effect for the sequential parallel design." Stat Med 30, no. 30 (2011): 3496-506.
Therapeutic Equivalency
Psioda, Matthew A., Kuolung Hu, Yang Zhang, Jean Pan, and Joseph G. Ibrahim. "Bayesian design of biosimilars clinical programs involving multiple therapeutic indications." Biometrics 76, no. 2 (2020): 630-642.
Therapies, Investigational
Jung, Sin-Ho, Myron N. Chang, and Sun J. Kang. "Phase II cancer clinical trials with heterogeneous patient populations." J Biopharm Stat 22, no. 2 (2012): 312-28.
Thiazolidinediones
Chu, Haitao, Lei Nie, Yong Chen, Yi Huang, and Wei Sun. "Bivariate random effects models for meta-analysis of comparative studies with binary outcomes: methods for the absolute risk difference and relative risk." Stat Methods Med Res 21, no. 6 (2012): 621-33.
Thioguanine
Appell, Malin L., Jonathan Berg, John Duley, William E. Evans, Martin A. Kennedy, Lynne Lennard, Tony Marinaki, Howard L. McLeod, Mary V. Relling, Elke Schaeffeler et al. "Nomenclature for alleles of the thiopurine methyltransferase gene." Pharmacogenet Genomics 23, no. 4 (2013): 242-8.
Thoracic Surgery, Video-Assisted
Wang, Xiaofei, and Mark F. Berry. "Risk calculators are useful but..." J Thorac Cardiovasc Surg 151, no. 3 (2016): 706-707.
Thrombocytopenia
Diéras, Véronique, David Miles, Sunil Verma, Mark Pegram, Manfred Welslau, José Baselga, Ian E. Krop, Kim Blackwell, Silke Hoersch, Jin Xu et al. "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial." Lancet Oncol 18, no. 6 (2017): 732-742.
Ticlopidine
Roe, Matthew T., Derek D. Cyr, Debra Eckart, Phillip J. Schulte, Michael A. Morse, Kimberly L. Blackwell, Neal E. Ready, Yousuf S Zafar, Anne W. Beaven, John H. Strickler et al. "Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome." Eur Heart J 37, no. 4 (2016): 412-22.
Time
Zhou, Qingning, Jianwen Cai, and Haibo Zhou. "Semiparametric inference for a two-stage outcome-dependent sampling design with interval-censored failure time data." Lifetime Data Anal 26, no. 1 (2020): 85-108.
Time Factors
Daniel, Rhian M., and Anastasios A. Tsiatis. "Efficient estimation of the distribution of time to composite endpoint when some endpoints are only partially observed." Lifetime Data Anal 19, no. 4 (2013): 513-46.
Samsky, Marc D., Chetan B. Patel, Ashleigh Owen, Phillip J. Schulte, Jacob Jentzer, Paul B. Rosenberg, Michael G Felker, Carmelo A. Milano, Adrian F. Hernandez, and Joseph G. Rogers. "Ten-year experience with extended criteria cardiac transplantation." Circ Heart Fail 6, no. 6 (2013): 1230-8.
Sohn, Insuk, Kouros Owzar, Stephen L. George, Sujong Kim, and Sin-Ho Jung. "Robust test method for time-course microarray experiments." BMC Bioinformatics 11 (2010): 391.
Diao, Guoqing, Jun Dong, Donglin Zeng, Chunlei Ke, Alan Rong, and Joseph G. Ibrahim. "Biomarker threshold adaptive designs for survival endpoints." J Biopharm Stat 28, no. 6 (2018): 1038-1054.
Phanstiel, Douglas H., Kevin Van Bortle, Damek Spacek, Gaelen T. Hess, Muhammad Saad Shamim, Ido Machol, Michael I. Love, Erez Lieberman Aiden, Michael C. Bassik, and Michael P. Snyder. "Static and Dynamic DNA Loops form AP-1-Bound Activation Hubs during Macrophage Development." Mol Cell 67, no. 6 (2017): 1037-1048.e6.
Chen, Liddy M., Joseph G. Ibrahim, and Haitao Chu. "Sample size determination in shared frailty models for multivariate time-to-event data." J Biopharm Stat 24, no. 4 (2014): 908-23.
Zhao, Yue, Amy H. Herring, Haibo Zhou, Mirza W. Ali, and Gary G. Koch. "A multiple imputation method for sensitivity analyses of time-to-event data with possibly informative censoring." J Biopharm Stat 24, no. 2 (2014): 229-53.
Kong, Dehan, Joseph G. Ibrahim, Eunjee Lee, and Hongtu Zhu. "FLCRM: Functional linear cox regression model." Biometrics 74, no. 1 (2018): 109-117.
Jiang, Xiaotong, Amanda E. Nelson, Rebecca J. Cleveland, Daniel P. Beavers, Todd A. Schwartz, Liubov Arbeeva, Carolina Alvarez, Leigh F. Callahan, Stephen Messier, Richard Loeser et al. "Precision Medicine Approach to Develop and Internally Validate Optimal Exercise and Weight-Loss Treatments for Overweight and Obese Adults With Knee Osteoarthritis: Data From a Single-Center Randomized Trial." Arthritis Care Res (Hoboken) 73, no. 5 (2021): 693-701.
Gao, Fei, Donglin Zeng, and Dan-Yu Lin. "Semiparametric estimation of the accelerated failure time model with partly interval-censored data." Biometrics 73, no. 4 (2017): 1161-1168.
Vock, David M., Michael T. Durheim, Wayne M. Tsuang, Ashley Finlen C Copeland, Anastasios A. Tsiatis, Marie Davidian, Megan L. Neely, David J. Lederer, and Scott M. Palmer. "Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation." Ann Am Thorac Soc 14, no. 2 (2017): 172-181.
Olby, Natasha J., Ji-Hey Lim, Nikki Wagner, Natalia Zidan, Peter J. Early, Christopher L. Mariani, Karen R. Muñana, and Eric Laber. "Time course and prognostic value of serum GFAP, pNFH, and S100β concentrations in dogs with complete spinal cord injury because of intervertebral disc extrusion." J Vet Intern Med 33, no. 2 (2019): 726-734.

Pages